General Information of Drug (ID: DMRK4FA)

Drug Name
N-(2-aminoethyl)-1-aziridine-ethanamine Drug Info
Synonyms NAAE; N-(2-aminoethyl)-1-aziridineethanamine
Indication
Disease Entry ICD 11 Status REF
Severe acute respiratory syndrome (SARS) 1D65 Investigative [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
PubChem CID
98888
ChEBI ID
CHEBI:145998
CAS Number
CAS 23435-23-6
TTD Drug ID
DMRK4FA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Drug Name Drug ID Indication ICD 11 Highest Status REF
rhACE2 DMBSXR9 Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 Trial [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN angiotensin-converting enzyme 2 (ACE2) TTYRG7F ACE2_HUMAN Inhibitor [1]

References

1 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
2 ClinicalTrials.gov (NCT04287686) Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19